Logs: Bang Zheng
The following is a list of all job requests run via OpenSAFELY by Bang Zheng.
| Status | Organisation | Project | Workspace | Request ID | Backend | Jobs | Started | View request |
|---|---|---|---|---|---|---|---|---|
| Succeeded | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | sotrovimab_molnupiravir | 13610 | TPP | 1/1 | 3 years, 3 months ago 29 November 2022 23:22:48 UTC | View, Job request 13610 |
| Succeeded | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | sotrovimab_molnupiravir | 13607 | TPP | 1/1 | 3 years, 3 months ago 29 November 2022 21:32:51 UTC | View, Job request 13607 |
| Failed | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | sotrovimab_molnupiravir | 13602 | TPP | 0/1 | 3 years, 3 months ago 29 November 2022 15:20:25 UTC | View, Job request 13602 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 13569 | TPP | 1/1 | 3 years, 3 months ago 28 November 2022 11:20:32 UTC | View, Job request 13569 |
| Succeeded | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | sotrovimab_molnupiravir | 13535 | TPP | 1/1 | 3 years, 3 months ago 26 November 2022 13:34:21 UTC | View, Job request 13535 |
| Failed | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | sotrovimab_molnupiravir | 13163 | TPP | 1/2 | 3 years, 3 months ago 14 November 2022 15:45:46 UTC | View, Job request 13163 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 13048 | TPP | 1/1 | 3 years, 3 months ago 09 November 2022 16:39:08 UTC | View, Job request 13048 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 13046 | TPP | 0/1 | 3 years, 3 months ago 09 November 2022 16:20:26 UTC | View, Job request 13046 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 13039 | TPP | 1/2 | 3 years, 3 months ago 09 November 2022 11:54:52 UTC | View, Job request 13039 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 13035 | TPP | 1/1 | 3 years, 3 months ago 09 November 2022 10:40:02 UTC | View, Job request 13035 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 13034 | TPP | 0/1 | - | View, Job request 13034 |
| Succeeded | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | sotrovimab_molnupiravir | 12825 | TPP | 2/2 | 3 years, 4 months ago 30 October 2022 23:01:03 UTC | View, Job request 12825 |
| Succeeded | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | sotrovimab_molnupiravir | 12818 | TPP | 1/1 | 3 years, 4 months ago 30 October 2022 15:25:49 UTC | View, Job request 12818 |
| Succeeded | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | sotrovimab_molnupiravir | 12814 | TPP | 2/2 | 3 years, 4 months ago 30 October 2022 11:04:40 UTC | View, Job request 12814 |
| Succeeded | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | sotrovimab_molnupiravir | 12806 | TPP | 1/1 | 3 years, 4 months ago 28 October 2022 21:30:15 UTC | View, Job request 12806 |
| Failed | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | sotrovimab_molnupiravir | 12802 | TPP | 0/1 | 3 years, 4 months ago 28 October 2022 16:57:24 UTC | View, Job request 12802 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12731 | TPP | 2/2 | 3 years, 4 months ago 27 October 2022 14:17:48 UTC | View, Job request 12731 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12728 | TPP | 1/1 | 3 years, 4 months ago 27 October 2022 08:34:39 UTC | View, Job request 12728 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12726 | TPP | 1/1 | 3 years, 4 months ago 27 October 2022 08:04:03 UTC | View, Job request 12726 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12725 | TPP | 1/1 | 3 years, 4 months ago 27 October 2022 07:57:57 UTC | View, Job request 12725 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12724 | TPP | 2/2 | 3 years, 4 months ago 27 October 2022 07:35:11 UTC | View, Job request 12724 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12723 | TPP | 1/1 | 3 years, 4 months ago 27 October 2022 07:07:41 UTC | View, Job request 12723 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12722 | TPP | 0/1 | 3 years, 4 months ago 27 October 2022 06:49:46 UTC | View, Job request 12722 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12721 | TPP | 1/2 | 3 years, 4 months ago 27 October 2022 06:10:30 UTC | View, Job request 12721 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12720 | TPP | 1/2 | 3 years, 4 months ago 26 October 2022 22:30:17 UTC | View, Job request 12720 |